HTA publishes a review of achievements for 2023/24.
Lynne Berry CBE, Chair of the Human Tissue Authority said:
“We set ourselves an ambitious agenda and I am proud to say we delivered real, tangible impact. We drove forward efficiencies in our regulatory approach by taking a more proportionate stance using new and updated regulatory tools. We also developed how we engage with our licensed establishments and key stakeholders to better understand their experiences and gain insights.”
During this time, we worked to ensure the safe and trusted use of human tissue in our regulated sectors by improving compliance, supporting innovation and developing a strong reputation as an efficient and expert regulator
Looking ahead, Dr Colin Sullivan, Chief Executive said:
“In 2024/25 we will continue to be a proportionate, effective and forward-looking regulator. Our values of collaboration, openness, respect and excellence will again underpin how we ensure human tissue is handled safely and with proper consent.”
We continue to adapt our regulatory approach so patients and their families can be confident that their tissue will be used in line with their wishes and handled with care.
We invite you to read the full 2023-24 review to learn more about our achievements.